PGL 0.00% 85.0¢ prospa group limited.

hey downramper TobagoJack,You have a couple errors in your...

  1. 26 Posts.
    hey downramper TobagoJack,

    You have a couple errors in your logic.

    "If the mechanism was sound for liver cancer, then some activity - any activity - would have been reported for lung cancer."

    Remember, liver was a monotherapy trial. And, this lung trial was a combo w/ Taxotere. They do mention that there are 9 patients on just PI-88 that have interesting signs worth looking into further.

    "The future of PI-88 as a viable drug for multiple conditions is now dead."

    Wrong again. There are other trials on-going - Melanoma, Multiple Myeloma, Prostate.....but you knew this already, right?

    And, if they decide to pursue a lung monotherapy trial.........???

    Time for you to go on lunch break....isn't your boss asking you to clock out yet?
 
watchlist Created with Sketch. Add PGL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.